Compare GOSS & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOSS | CCNE |
|---|---|---|
| Founded | 2015 | 1865 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.8M | 736.3M |
| IPO Year | 2019 | N/A |
| Metric | GOSS | CCNE |
|---|---|---|
| Price | $3.57 | $27.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $8.60 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 3.3M | 130.1K |
| Earning Date | 11-05-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | $44,051,000.00 | ★ $227,923,000.00 |
| Revenue This Year | N/A | $13.84 |
| Revenue Next Year | $6.41 | $27.68 |
| P/E Ratio | ★ N/A | $14.56 |
| Revenue Growth | N/A | ★ 5.27 |
| 52 Week Low | $0.76 | $19.32 |
| 52 Week High | $3.87 | $28.04 |
| Indicator | GOSS | CCNE |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 63.07 |
| Support Level | $3.53 | $27.55 |
| Resistance Level | $3.87 | $28.01 |
| Average True Range (ATR) | 0.24 | 0.49 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 51.96 | 67.35 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.